Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim H, Rubin P, Ortiz H. Cox JD, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1191-5. doi: 10.1016/0360-3016(91)90227-u. Int J Radiat Oncol Biol Phys. 1991. PMID: 2045293 Clinical Trial.
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.
Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LE. Cox JD, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):505-9. doi: 10.1016/s0360-3016(98)00429-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078629
Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313.
Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim HM, Byhardt RW, Rubin P, Ortiz HG, et al. Cox JD, et al. Among authors: fu kk. Cancer. 1992 Jun 1;69(11):2744-8. doi: 10.1002/1097-0142(19920601)69:11<2744::aid-cncr2820691119>3.0.co;2-u. Cancer. 1992. PMID: 1571904 Clinical Trial.
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
Cox JD, Pajak TF, Marcial VA, Hanks GE, Mohiuddin M, Fu KK, Byhardt RW, Rubin P. Cox JD, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):515-21. doi: 10.1016/0360-3016(90)90054-n. Int J Radiat Oncol Biol Phys. 1990. PMID: 2180866 Clinical Trial.
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK; Radiation Therapy Oncology Group. Machtay M, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. doi: 10.1016/j.ijrobp.2007.04.063. Epub 2007 Aug 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17716826 Clinical Trial.
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ, et al. Lee DJ, et al. Among authors: fu kk. Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):567-76. doi: 10.1016/0360-3016(95)00150-W. Int J Radiat Oncol Biol Phys. 1995. PMID: 7790241 Free article. Clinical Trial.
178 results